3048 companies

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)

Market Cap: ج.م6.1b

Produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt.

RMDA

ج.م4.06

7D

-5.1%

1Y

57.4%

Alterity Therapeutics

Market Cap: AU$119.7m

Engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia.

ATH

AU$0.013

7D

-7.1%

1Y

333.3%

Tibet Weixinkang Medicine

Market Cap: CN¥5.3b

Engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China.

603676

CN¥12.30

7D

-0.2%

1Y

62.1%

Concord Biotech

Market Cap: ₹173.4b

A biopharma company, engages in the research and development, manufacture, market, and sale of pharmaceutical products in India and internationally.

CONCORDBIO

₹1,657.70

7D

-1.4%

1Y

-9.7%

Boji Medical TechnologyLtd

Market Cap: CN¥4.1b

Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.

300404

CN¥10.82

7D

-0.6%

1Y

49.7%

Vita Life Sciences

Market Cap: AU$135.3m

A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.

VLS

AU$2.42

7D

5.2%

1Y

5.7%

Aether Industries

Market Cap: ₹98.3b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

AETHER

₹741.55

7D

0.7%

1Y

-20.7%

Panchsheel Organics

Market Cap: ₹1.7b

Engages in the manufacture and trading of bulk drugs and intermediates in India and internationally.

531726

₹147.90

7D

-2.1%

1Y

-47.3%

AstraZeneca

Market Cap: UK£189.0b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

AZN

UK£120.90

7D

2.5%

1Y

-4.4%

GSK

Market Cap: UK£59.2b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

GSK

UK£14.76

7D

1.6%

1Y

-10.6%

Niagen Bioscience

Market Cap: US$744.9m

Operates as a bioscience company engages in developing healthy aging products.

NAGE

US$9.41

7D

-4.9%

1Y

182.6%

Medpace Holdings

Market Cap: US$13.6b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

MEDP

US$486.98

7D

2.4%

1Y

45.0%

Evoke Pharma

Market Cap: US$11.0m

Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.

EVOK

US$5.21

7D

-4.4%

1Y

34.6%

Invivyd

Market Cap: US$202.8m

A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.

IVVD

US$1.00

7D

0.8%

1Y

17.2%

Hualan Biological Engineering

Market Cap: CN¥30.8b

A biopharmaceutical company, researches, develops, produces, and commercializes blood products, vaccines, and recombinant proteins in China and internationally.

002007

CN¥16.83

7D

-1.6%

1Y

12.7%

Chi Sheng Pharma & Biotech

Market Cap: NT$2.0b

Engages in the manufacturing, processing, sale, and import and export trade of pharmaceuticals, medical products, cosmetics, health foods, and medical equipment in Taiwan and internationally.

4111

NT$32.65

7D

4.5%

1Y

32.1%

Syngen BiotechLtd

Market Cap: NT$3.3b

Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.

8279

NT$122.50

7D

1.2%

1Y

-8.9%

IOL Chemicals and Pharmaceuticals

Market Cap: ₹28.5b

Manufactures and sells pharmaceutical and chemical products in India and internationally.

524164

₹96.93

7D

6.8%

1Y

4.1%

Modern Chinese Medicine Group

Market Cap: HK$496.8m

An investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China.

1643

HK$0.69

7D

-1.4%

1Y

122.6%

Novartis India

Market Cap: ₹23.0b

Novartis India Limited is involved in the pharmaceutical business in India.

500672

₹932.40

7D

0.9%

1Y

-14.5%

Standard Chemical & Pharmaceutical

Market Cap: NT$10.1b

Standard Chemical & Pharmaceutical Co. Ltd.

1720

NT$56.60

7D

0.5%

1Y

-12.8%

Procter & Gamble Health

Market Cap: ₹107.3b

Manufactures and markets pharmaceuticals and chemical products in India and internationally.

500126

₹6,465.40

7D

1.6%

1Y

23.0%

Chong Kun Dang Pharmaceutical

Market Cap: ₩1.1t

Engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally.

A185750

₩81,200.00

7D

1.6%

1Y

-22.9%

Towa Pharmaceutical

Market Cap: JP¥149.2b

Manufactures and sale ethical drugs in Japan.

4553

JP¥3,030.00

7D

4.5%

1Y

2.7%

Yantai Zhenghai Biotechnology

Market Cap: CN¥3.6b

Engages in the research and development, production, and marketing of regenerative medical materials in China.

300653

CN¥20.37

7D

-2.8%

1Y

7.9%

Vistin Pharma

Market Cap: NOK 1.0b

Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.

VISTN

NOK 23.30

7D

-2.1%

1Y

-2.9%

Anhui Anke Biotechnology (Group)

Market Cap: CN¥18.6b

Anhui Anke Biotechnology (Group) Co., Ltd.

300009

CN¥11.14

7D

-0.7%

1Y

43.2%

Genovis AB (publ.)

Market Cap: SEK 1.5b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

GENO

SEK 23.00

7D

-3.6%

1Y

-1.9%

Incyte

Market Cap: US$16.7b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

INCY

US$86.64

7D

2.4%

1Y

41.4%

Protagonist Therapeutics

Market Cap: US$3.6b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

PTGX

US$59.60

7D

2.5%

1Y

41.8%

MannKind

Market Cap: US$1.7b

A biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States.

MNKD

US$5.34

7D

18.9%

1Y

-11.4%

Gland Pharma

Market Cap: ₹311.8b

Engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.

GLAND

₹1,892.20

7D

1.1%

1Y

-0.7%

Pacific Shuanglin Bio-pharmacy

Market Cap: CN¥17.1b

Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in research, development, production, and sales of blood products in China.

000403

CN¥18.00

7D

1.7%

1Y

-3.7%

Daihan PharmaceuticalLtd

Market Cap: ₩177.6b

Engages in the manufacture and sale of therapeutic drugs in South Korea.

A023910

₩30,200.00

7D

2.2%

1Y

17.5%

Acutaas Chemicals

Market Cap: ₹120.7b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

ACUTAAS

₹1,474.60

7D

4.9%

1Y

108.3%

BioNote

Market Cap: ₩574.7b

Manufactures and sells in-vitro diagnostic animal medicines in South Korea.

A377740

₩5,670.00

7D

-0.4%

1Y

25.0%

Page 9 of 85